المؤلفون: Dhana A; Department of Medicine, University of Cape Town, Cape Town, South Africa., Hamada Y; Centre for International Cooperation and Global Tuberculosis Information, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan; Institute for Global Health, University College London, London, UK., Kengne AP; Non-communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa., Kerkhoff AD; Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California, San Francisco, CA, USA., Rangaka MX; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Institute for Global Health, University College London, London, UK., Kredo T; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa., Baddeley A; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Miller C; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Singh S; Global HIV, Hepatitis and STIs Programme, World Health Organization, Geneva, Switzerland., Hanifa Y; TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Grant AD; TB Centre, London School of Hygiene & Tropical Medicine, London, UK; Africa Health Research Institute, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa., Fielding K; TB Centre, London School of Hygiene & Tropical Medicine, London, UK., Affolabi D; Laboratoire de Référence des Mycobactéries, Cotonou, Benin., Merle CS; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Geneva, Switzerland., Wachinou AP; National Hospital for Tuberculosis and Pulmonary Diseases, Cotonou, Benin., Yoon C; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Tuberculosis, University of California, San Francisco, CA, USA., Cattamanchi A; Department of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Tuberculosis, University of California, San Francisco, CA, USA., Hoffmann CJ; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Martinson N; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa; Johns Hopkins University Center for Tuberculosis Research, Baltimore, MD, USA., Mbu ET; Bamenda Regional Hospital HIV Treatment Center, Bamenda, Cameroon., Sander MS; Tuberculosis Reference Laboratory Bamenda, Bamenda, Cameroon., Balcha TT; Clinical Infection Medicine, Lund University, Malmö, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden., Skogmar S; Department of Translational Medicine, Lund University, Malmö, Sweden., Reeve BWP; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa., Theron G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa., Ndlangalavu G; DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, Western Cape, South Africa., Modi S; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Cavanaugh J; US Centers for Disease Control and Prevention, Atlanta, GA, USA., Swindells S; University of Nebraska Medical Center, Omaha, NE, USA., Chaisson RE; Johns Hopkins University Center for Tuberculosis Research, Baltimore, MD, USA., Ahmad Khan F; McGill International Tuberculosis Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Howard AA; ICAP at Columbia University, New York, NY, USA; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA., Wood R; Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa., Thit SS; Department of Medicine, University of Medicine 2, Yangon, Yangon Division, Myanmar., Kyi MM; Department of Medicine, University of Medicine 2, Yangon, Yangon Division, Myanmar., Hanson J; The Kirby Institute, University of New South Wales, Sydney, NSW, Australia., Drain PK; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA., Shapiro AE; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA., Kufa T; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; Centre for HIV and STIs, National Institute for Communicable Diseases, Johannesburg, South Africa., Churchyard G; School of Public Health, University of the Witwatersrand, Johannesburg, South Africa; The Aurum Institute, Parktown, South Africa., Nguyen DT; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA., Graviss EA; Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, TX, USA., Bjerrum S; Department of Clinical Research, Infectious Diseases, University of Southern Denmark, Odense, Denmark., Johansen IS; Research Unit for Infectious Diseases, Odense University Hospital, University of Southern Denmark, Odense, Denmark., Gersh JK; University of Washington, Seattle, WA, USA., Horne DJ; Department of Medicine, Division of Infectious Diseases, University of Washington, Seattle, WA, USA., LaCourse SM; Department of Medicine, Division of Infectious Diseases, University of Washington, Seattle, WA, USA; Department of Global Health, Division of Infectious Diseases, University of Washington, Seattle, WA, USA., Al-Darraji HAA; Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia., Kamarulzaman A; Centre of Excellence for Research in AIDS, University of Malaya, Kuala Lumpur, Malaysia., Kempker RR; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA., Tukvadze N; National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia., Barr DA; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK., Meintjes G; Department of Medicine, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Maartens G; Department of Medicine, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: gary.maartens@uct.ac.za.

المصدر: The Lancet. Infectious diseases [Lancet Infect Dis] 2022 Apr; Vol. 22 (4), pp. 507-518. Date of Electronic Publication: 2021 Nov 17.

نوع المنشور: Journal Article; Meta-Analysis; Systematic Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antibiotics, Antitubercular*/therapeutic use , HIV Infections*/complications , HIV Infections*/drug therapy , Mycobacterium tuberculosis* , Tuberculosis*/diagnosis , Tuberculosis, Pulmonary*/diagnosis , Tuberculosis, Pulmonary*/drug therapy, Adolescent ; Adult ; Child ; Cross-Sectional Studies ; Humans ; Prospective Studies ; Rifampin ; Sensitivity and Specificity

المؤلفون: Naning H; 1 Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Al-Darraji HAA; 1 Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; 2 Centre for International Health, Department of Preventive and Social Medicine, University of Otago School of Medicine, University of Otago, Dunedin, New Zealand., McDonald S; 1 Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; 3 Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.; 4 School of Health & Life Sciences, Glasgow Caledonian University, Glasgow, Scotland., Ismail NA; 5 Department of Applied Statistics, Faculty of Economics and Administration, University of Malaya, Kuala Lumpur, Malaysia., Kamarulzaman A; 1 Centre of Excellence for Research in AIDS (CERiA), Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

المصدر: Asia-Pacific journal of public health [Asia Pac J Public Health] 2018 Apr; Vol. 30 (3), pp. 235-243. Date of Electronic Publication: 2018 Mar 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SAGE Publications Country of Publication: China NLM ID: 8708538 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-2479 (Electronic) Linking ISSN: 10105395 NLM ISO Abbreviation: Asia Pac J Public Health

مواضيع طبية MeSH: Crowding* , Prisons*, Prisoners/*statistics & numerical data , Tuberculosis/*prevention & control, Humans ; Malaysia/epidemiology ; Models, Biological ; Prevalence ; Program Evaluation ; Tuberculosis/epidemiology